JPND is seeking to develop public-private partnerships with industry in key priority areas for implementation. Ongoing engagement with the Innovative Medicines Initiative aims to ensure that JPND scientific priorities align with those of the pharmaceutical industry and promote public-private partnerships.
JPND will look to expand this engagement to the Diagnostic, IT, Medical Device and Imaging industries, as well as to Small-to-Medium Enterprises (SMEs) with relevance to neurodegenerative diseases.
In October 2017, JPND hosted a workshop with the private sector to address how academia-industry collaborations could accelerate the development of innovative diagnostic tools and therapies for neurodegenerative diseases. The feedback gathered at the meeting will be used to improve JPND’s ongoing and future strategy for engagement with industry. To learn more about the event, click here.
A survey on JPND – Industry Collaboration in Neurodegenerative Disease Research is ongoing. It aims to help JPND better understand the interests and needs of companies working in the field. Your feedback is welcome. Please scroll down to fill out the questionnaire and leave your suggestions.